Day One Biopharmaceuticals, Inc.
8 clinical trials · Sponsor
◉ Watch Day One Biopharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) (NCT05566795) | Day One Biopharmaceuticals, Inc. | 2023-02-27 |
| A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 (NCT05514717) | Day One Biopharmaceuticals, Inc. | 2023-01-24 |
| A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors (NCT05377996) | Day One Biopharmaceuticals, Inc. | 2022-08-15 |
| Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors (NCT07121829) | Day One Biopharmaceuticals, Inc. | 2022-05-02 |
| Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors (NCT04985604) | Day One Biopharmaceuticals, Inc. | 2021-07-15 |
Track Day One Biopharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.